First Description of Novel End-Organ Effects by Speed Modulation Using the Aortix™ Device

Figure 1

Design of the Aortix™ (manufacturer Procyrion) novel percutaneous mechanical circulatory support device. (a) Aortix™ device demonstrating its 18F axial flow structure. (b) Aortix™ device demonstrating its 6F transfemoral artery power lead and atraumatic nitinol struts for dynamic stabilization in the vessel (permission granted from Procyrion for use of copyright images). F = French.

(a)

(b)